---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-267232"
form_type: "8-K"
ticker: "GLUE"
cik: "0001826457"
company_name: "Monte Rosa Therapeutics, Inc."
filed_at: "2022-10-24T23:59:59+00:00"
generated_at: "2026-06-23T01:42:51.796325+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Monte Rosa holds KOL webinar on MRT-2359 hosted by Cowen on Oct 24, 2022

## Summary
- Presented at KOL webinar hosted by Cowen on MRT-2359, a targeted protein degrader.
- Guest speakers included Jordi Rodon Ahnert (MD Anderson) and Davide Ruggero (UCSF).
- No specific clinical or financial data disclosed in the filing or exhibit.

## SEC filing metadata
- accession: 0001193125-22-267232
- form_type: 8-K
- ticker: GLUE
- cik: 0001826457
- company_name: Monte Rosa Therapeutics, Inc.
- filed_at: 2022-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826457/000119312522267232/0001193125-22-267232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826457/000119312522267232/d412446d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-267232
- JSON: https://secwatch.observer/filing/0001193125-22-267232.json
- Plain text: https://secwatch.observer/filing/0001193125-22-267232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.